PADCEV

PADCEV (enfortumab vedotin) Now Available in India for Locally Advanced or Metastatic Urothelial Cancer

Brand connect Initiative- Enfortumab vedotin is now available for patients who received prior platinum-containing chemotherapy and a PD-1/L1 inhibitor